Altamira Therapeutics Ltd (CYTO) has fallen Wednesday morning, with the stock declining -4.13% in pre-market trading to 2.32.
CYTO's short-term technical score of 29 indicates that the stock has traded less bullishly over the last month than 71% of stocks on the market. In the Biotechnology industry, which ranks 100 out of 146 industries, Altamira Therapeutics Ltd ranks higher than 41% of stocks.
Altamira Therapeutics Ltd has risen 34.44% over the past month, closing at $1.80 on February 28. During this period of time, the stock fell as low as $1.68 and as high as $3.49.
CYTO has an Overall Score of 21. Find out what this means to you and get the rest of the rankings on CYTO!
Altamira Therapeutics Ltd has a Long-Term Technical rank of 34. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 66% of the market scoring higher. In the Biotechnology industry which is number 69 by this metric, CYTO ranks better than 69% of stocks.
